239 related articles for article (PubMed ID: 18664548)
1. Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women.
Phipps AI; Malone KE; Porter PL; Daling JR; Li CI
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2078-86. PubMed ID: 18664548
[TBL] [Abstract][Full Text] [Related]
2. Association between common risk factors and molecular subtypes in breast cancer patients.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738
[TBL] [Abstract][Full Text] [Related]
3. Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer.
Chen L; Cook LS; Tang MT; Porter PL; Hill DA; Wiggins CL; Li CI
Breast Cancer Res Treat; 2016 Jun; 157(3):545-54. PubMed ID: 27220749
[TBL] [Abstract][Full Text] [Related]
4. Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women.
Islam T; Matsuo K; Ito H; Hosono S; Watanabe M; Iwata H; Tajima K; Tanaka H
Ann Oncol; 2012 Sep; 23(9):2435-2441. PubMed ID: 22328736
[TBL] [Abstract][Full Text] [Related]
5. Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer.
Phipps AI; Malone KE; Porter PL; Daling JR; Li CI
Cancer; 2008 Oct; 113(7):1521-6. PubMed ID: 18726992
[TBL] [Abstract][Full Text] [Related]
6. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
7. Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women.
Miyagawa Y; Miyake T; Yanai A; Murase K; Imamura M; Ichii S; Takatsuka Y; Ito T; Hirota S; Saito M; Kotoura Y; Miyauchi K; Fujimoto Y; Hatada T; Sasa M; Miyoshi Y
Breast Cancer; 2015 Jul; 22(4):399-405. PubMed ID: 24000037
[TBL] [Abstract][Full Text] [Related]
8. Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women.
Horn J; Alsaker MD; Opdahl S; Engstrøm MJ; Tretli S; Haugen OA; Bofin AM; Vatten LJ; Asvold BO
Int J Cancer; 2014 Dec; 135(11):2678-86. PubMed ID: 24752603
[TBL] [Abstract][Full Text] [Related]
9. Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women.
Crispo A; Montella M; Buono G; Grimaldi M; D'Aiuto M; Capasso I; Esposito E; Amore A; Nocerino F; Augustin LS; Giudice A; Di Bonito M; Giuliano M; Forestieri V; De Laurentiis M; Rinaldo M; Ciliberto G; De Placido S; Arpino G
Curr Res Transl Med; 2016; 64(1):15-20. PubMed ID: 27140595
[TBL] [Abstract][Full Text] [Related]
10. Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk.
Cui Y; Deming-Halverson SL; Beeghly-Fadiel A; Lipworth L; Shrubsole MJ; Fair AM; Shu XO; Zheng W
Clin Cancer Res; 2014 Mar; 20(5):1169-78. PubMed ID: 24423614
[TBL] [Abstract][Full Text] [Related]
11. The association between body mass index and immunohistochemical subtypes in breast cancer.
Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
[TBL] [Abstract][Full Text] [Related]
12. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer.
Phipps AI; Chlebowski RT; Prentice R; McTiernan A; Stefanick ML; Wactawski-Wende J; Kuller LH; Adams-Campbell LL; Lane D; Vitolins M; Kabat GC; Rohan TE; Li CI
Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):454-63. PubMed ID: 21364029
[TBL] [Abstract][Full Text] [Related]
13. Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis.
Ma H; Ursin G; Xu X; Lee E; Togawa K; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Lu Y; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
Breast Cancer Res; 2018 Jan; 20(1):5. PubMed ID: 29357906
[TBL] [Abstract][Full Text] [Related]
14. Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.
Jung AY; Ahearn TU; Behrens S; Middha P; Bolla MK; Wang Q; Arndt V; Aronson KJ; Augustinsson A; Beane Freeman LE; Becher H; Brenner H; Canzian F; Carey LA; ; Czene K; Eliassen AH; Eriksson M; Evans DG; Figueroa JD; Fritschi L; Gabrielson M; Giles GG; Guénel P; Hadjisavvas A; Haiman CA; Håkansson N; Hall P; Hamann U; Hoppe R; Hopper JL; Howell A; Hunter DJ; Hüsing A; Kaaks R; Kosma VM; Koutros S; Kraft P; Lacey JV; Le Marchand L; Lissowska J; Loizidou MA; Mannermaa A; Maurer T; Murphy RA; Olshan AF; Olsson H; Patel AV; Perou CM; Rennert G; Shibli R; Shu XO; Southey MC; Stone J; Tamimi RM; Teras LR; Troester MA; Truong T; Vachon CM; Wang SS; Wolk A; Wu AH; Yang XR; Zheng W; Dunning AM; Pharoah PDP; Easton DF; Milne RL; Chatterjee N; Schmidt MK; García-Closas M; Chang-Claude J
J Natl Cancer Inst; 2022 Dec; 114(12):1706-1719. PubMed ID: 35723569
[TBL] [Abstract][Full Text] [Related]
15. A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China.
Xing P; Li J; Jin F
Med Oncol; 2010 Sep; 27(3):926-31. PubMed ID: 19771534
[TBL] [Abstract][Full Text] [Related]
16. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
Yang XR; Chang-Claude J; Goode EL; Couch FJ; Nevanlinna H; Milne RL; Gaudet M; Schmidt MK; Broeks A; Cox A; Fasching PA; Hein R; Spurdle AB; Blows F; Driver K; Flesch-Janys D; Heinz J; Sinn P; Vrieling A; Heikkinen T; Aittomäki K; Heikkilä P; Blomqvist C; Lissowska J; Peplonska B; Chanock S; Figueroa J; Brinton L; Hall P; Czene K; Humphreys K; Darabi H; Liu J; Van 't Veer LJ; van Leeuwen FE; Andrulis IL; Glendon G; Knight JA; Mulligan AM; O'Malley FP; Weerasooriya N; John EM; Beckmann MW; Hartmann A; Weihbrecht SB; Wachter DL; Jud SM; Loehberg CR; Baglietto L; English DR; Giles GG; McLean CA; Severi G; Lambrechts D; Vandorpe T; Weltens C; Paridaens R; Smeets A; Neven P; Wildiers H; Wang X; Olson JE; Cafourek V; Fredericksen Z; Kosel M; Vachon C; Cramp HE; Connley D; Cross SS; Balasubramanian SP; Reed MW; Dörk T; Bremer M; Meyer A; Karstens JH; Ay A; Park-Simon TW; Hillemanns P; Arias Pérez JI; Menéndez Rodríguez P; Zamora P; Benítez J; Ko YD; Fischer HP; Hamann U; Pesch B; Brüning T; Justenhoven C; Brauch H; Eccles DM; Tapper WJ; Gerty SM; Sawyer EJ; Tomlinson IP; Jones A; Kerin M; Miller N; McInerney N; Anton-Culver H; Ziogas A; Shen CY; Hsiung CN; Wu PE; Yang SL; Yu JC; Chen ST; Hsu GC; Haiman CA; Henderson BE; Le Marchand L; Kolonel LN; Lindblom A; Margolin S; Jakubowska A; Lubiński J; Huzarski T; Byrski T; Górski B; Gronwald J; Hooning MJ; Hollestelle A; van den Ouweland AM; Jager A; Kriege M; Tilanus-Linthorst MM; Collée M; Wang-Gohrke S; Pylkäs K; Jukkola-Vuorinen A; Mononen K; Grip M; Hirvikoski P; Winqvist R; Mannermaa A; Kosma VM; Kauppinen J; Kataja V; Auvinen P; Soini Y; Sironen R; Bojesen SE; Ørsted DD; Kaur-Knudsen D; Flyger H; Nordestgaard BG; Holland H; Chenevix-Trench G; Manoukian S; Barile M; Radice P; Hankinson SE; Hunter DJ; Tamimi R; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gaborieau V; Devilee P; Huijts PE; Tollenaar RA; Seynaeve C; Dite GS; Apicella C; Hopper JL; Hammet F; Tsimiklis H; Smith LD; Southey MC; Humphreys MK; Easton D; Pharoah P; Sherman ME; Garcia-Closas M
J Natl Cancer Inst; 2011 Feb; 103(3):250-63. PubMed ID: 21191117
[TBL] [Abstract][Full Text] [Related]
17. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Carey LA; Perou CM; Livasy CA; Dressler LG; Cowan D; Conway K; Karaca G; Troester MA; Tse CK; Edmiston S; Deming SL; Geradts J; Cheang MC; Nielsen TO; Moorman PG; Earp HS; Millikan RC
JAMA; 2006 Jun; 295(21):2492-502. PubMed ID: 16757721
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib.
Prat A; Cheang MC; Galván P; Nuciforo P; Paré L; Adamo B; Muñoz M; Viladot M; Press MF; Gagnon R; Ellis C; Johnston S
JAMA Oncol; 2016 Oct; 2(10):1287-1294. PubMed ID: 27281556
[TBL] [Abstract][Full Text] [Related]
19. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
[TBL] [Abstract][Full Text] [Related]
20. Impact of reproductive factors on breast cancer subtypes in postmenopausal women: a retrospective single-center study.
von Au A; Klotzbuecher M; Uhlmann L; Boudewijns M; Michel L; Wallwiener M; Heil J; Golatta M; Rom J; Sohn C; Schneeweiss A; Schuetz F; Domschke C
Arch Gynecol Obstet; 2017 Apr; 295(4):971-978. PubMed ID: 28176013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
